Igor Davydkin

Change of concentration of biochemical markers of dysfunction of endothelium at intake of inhibitors of tyrosinekinase of I and II generations at patients with a chronic myeloid leukemia as risk factor of development of cardiovascular complications

Within the last decades there was progress in treatment of oncological pathology, the amount of drugs for anticarcinogenic therapy which ...

K. Naumova I. Davydkin еще 4